P1 · research first
Medida AI
- Primary existing financial model: Medida
- Leading current comparative diligence: Choice
Profile
- Sector
- Constructiontech / computer-vision measurements
- Geography
- Israel / United States
- Reported financing
- $4M seed announced December 2025
Funding raised is not ARR or valuation.
- Funding stage
- Seed
- Public traction evidence (original desk screen, March 2026 era; see Phase 3 supplement for latest)
- $3M annualized revenue RATE reported Dec 2025; not verified subscription ARR; deployment across 35 US states
- Revenue disclosure status
- Not publicly verified
- 2026 revenue
- Not publicly verified
- Research priority
- P1 Order of further research; analyst judgment from the research package, not a recommendation.
- Investment readiness
- Investability unconfirmed. WATCH
- Core diligence concern
- Confirm contracted recurring ARR versus per-measurement and service revenue, accuracy and redo rates
- Mandate-fit hypothesis (analyst judgment, unverified)
- Construction workflow automation with U.S. customers and Israeli founders
Missing information
- 2026 actual revenue and KPIs
- Recurring vs usage vs services split
- Paying-customer count
- Round terms and fully diluted cap table
- Independent accuracy test results
Phase 3 research supplement
Comparative diligence v1.0, as of 2026-11-01. Separate from the original sourced research; older observations are kept.
Existing watch model Research priority label, not an investment approval.
| Observed | Metric | Reported value | Source | Status |
|---|---|---|---|---|
| 2025-12-10 | Annualized revenue rate (press-reported) Not verified subscription ARR. | Press-reported $3M (USD) | S08 independent news report with executive assertions, reporter cites executives. Medida seed funding report, CTech, December 10, 2025 (opens in new tab) | Latest |
| 2025-12-10 | U.S. states deployed | Reported 35 | S08 independent news report with executive assertions, reporter cites executives. Medida seed funding report, CTech, December 10, 2025 (opens in new tab) | Latest |
All values are management- or press-reported public statements. None is audited. ARR, net revenue retention, gross margin and 2026 valuation: Not publicly verified.
Principal risks
- Publication headline calls 2025 rate ARR, article body says annualized revenue, not a certified recurring-revenue schedule
- No corroborated full-year 2026 financials
- Company terms require on-site professional verification of AI-generated estimates
- Measurement and rework liability, installation error cost and contractually allocated risk
- Existing 2033 projection is illustrative, not sourced company guidance
Outstanding diligence requirements
- Reconcile 2025 run rate to 2026 actuals and break down subscription vs per-scan revenue
- Contracted recurring ARR proof with customer invoices and renewal terms
- Benchmark scan-to-install accuracy, redo rate and warranty claims
- Gross profit by revenue type and cost to serve
- Current round, valuation and dilution terms
Sourcing research collection
25-company desk screen. Each source supports only the stated funding, description and traction.
- Independent reporting Independent news report, published 2025-12-10
https://www.calcalistech.com/ctechnews/article/bj10jmvzzl (opens in new tab)
Scope: Funding, company description, and only the specific traction stated in public_traction_signal.
Original evidence records
Preserved from the original research file
Press / company statement, Dec 10 2025. Reliability: MEDIUM. Caveat: Reported raise, no verified capitalization or date reconciliations.
https://www.calcalistech.com/ctechnews/article/bj10jmvzzl (opens in new tab)Press / company statement, Dec 10 2025. Reliability: MEDIUM. Caveat: Article headline says ARR; body describes annual revenue rate.
https://www.calcalistech.com/ctechnews/article/bj10jmvzzl (opens in new tab)Company primary marketing, Nov 2026 access. Reliability: LOW / SELF CLAIM. Caveat: Unknown paid vs trial vs historical logos.
https://medida.ai/ (opens in new tab)